Microchemical Journal, Journal Year: 2024, Volume and Issue: 207, P. 112065 - 112065
Published: Nov. 1, 2024
Language: Английский
Microchemical Journal, Journal Year: 2024, Volume and Issue: 207, P. 112065 - 112065
Published: Nov. 1, 2024
Language: Английский
World Journal of Virology, Journal Year: 2023, Volume and Issue: 12(5), P. 242 - 255
Published: Dec. 25, 2023
RNA viruses continue to pose significant threats global public health, necessitating a profound understanding of their pathogenic mechanisms and the development effective therapeutic interventions. This manuscript provides comprehensive overview emerging perspectives on virus-mediated infections, spanning from intricate intricacies viral pathogenesis forefront innovative strategies. A critical exploration antiviral drugs sets stage, highlighting diverse classes compounds that target various stages life cycle, underscoring ongoing efforts combat infections. Central this discussion is RNA-based therapeutics, with spotlight messenger (mRNA)-based approaches have revolutionized landscape Furthermore, delves into world delivery systems, exploring inno-vative technologies designed enhance efficiency safety mRNA vaccines. By analyzing challenges advancements in mechanisms, review offers roadmap for future research area. Beyond conventional infectious diseases, document explores expanding applications vaccines, including promising roles cancer immunotherapy personalized medicine approaches. serves as valuable resource researchers, clinicians, policymakers alike, offering nuanced perspective virus cutting-edge synthesizing latest challenges, contributes significantly discourse field, driving novel strategies infections effectively.
Language: Английский
Citations
4Molecular Systems Design & Engineering, Journal Year: 2023, Volume and Issue: 8(11), P. 1337 - 1354
Published: Jan. 1, 2023
Numerous tests have been developed for early clinical detection of the novel coronavirus, COVID-19, including RT-PCR, rapid PCR, laminar flow tests, and large-scale decentralized screening SARS-CoV-2 in a point-of-care format.
Language: Английский
Citations
3Published: Jan. 1, 2024
Language: Английский
Citations
0Molecular Therapy — Nucleic Acids, Journal Year: 2024, Volume and Issue: 35(3), P. 102310 - 102310
Published: Aug. 15, 2024
Viral infections are one of the leading causes death in world. One main challenge fighting against these diseases is unavailability effective eradicating drugs and specific treatments. Nanocarriers aptamer-decorated nanocarriers designed to attach many targets, including viral particles. By lowering infectivity attachment capability, they add therapeutic values even without containing antiviral drugs. Nevertheless, nanoparticles (NPs) with encapsulated can display extra effects. Furthermore, it has been shown that aptamers bind particles nanocarriers, presenting promising approaches for identification viruses treatment infections. Although there no satisfying literature revealing strong potential nanotechnology COVID-19, following information provide new perspectives upcoming investigations pertaining developing aptamer-nanocarrier agents COVID-19.
Language: Английский
Citations
0Microchemical Journal, Journal Year: 2024, Volume and Issue: 207, P. 112065 - 112065
Published: Nov. 1, 2024
Language: Английский
Citations
0